Similar articles for PMID: 29928656

Year	Number of Results
1996	1
1999	1
2007	1
2009	1
2010	2
2011	2
2012	2
2013	2
2014	4
2015	9
2016	13
2017	18
2018	16
2019	10
2020	5
2021	5
2022	3
2023	2
2024	0

1

Long-term Phase 1/2 intraspinal stem cell transplantation outcomes in ALS.

Goutman SA, Brown MB, Glass JD, Boulis NM, Johe K, Hazel T, Cudkowicz M, Atassi N, Borges L, Patil PG, Sakowski SA, Feldman EL. Goutman SA, et al. Ann Clin Transl Neurol. 2018 May 2;5(6):730-740. doi: 10.1002/acn3.567. eCollection 2018 Jun. Ann Clin Transl Neurol. 2018. PMID: 29928656 Free PMC article.

2

ALS/SURV: a modification of the CAFS statistic.

Goutman SA, Brown MB, Cudkowicz M, Atassi N, Feldman EL. Goutman SA, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2019 Nov;20(7-8):576-583. doi: 10.1080/21678421.2019.1643375. Epub 2019 Jul 23. Amyotroph Lateral Scler Frontotemporal Degener. 2019. PMID: 31334681 Free PMC article.

3

Autologous bone marrow-derived stem cells in amyotrophic lateral sclerosis: a pilot study.

Prabhakar S, Marwaha N, Lal V, Sharma RR, Rajan R, Khandelwal N. Prabhakar S, et al. Neurol India. 2012 Sep-Oct;60(5):465-9. doi: 10.4103/0028-3886.103185. Neurol India. 2012. PMID: 23135021 Free article.

4

Intraspinal neural stem cell transplantation in amyotrophic lateral sclerosis: phase 1 trial outcomes.

Feldman EL, Boulis NM, Hur J, Johe K, Rutkove SB, Federici T, Polak M, Bordeau J, Sakowski SA, Glass JD. Feldman EL, et al. Ann Neurol. 2014 Mar;75(3):363-73. doi: 10.1002/ana.24113. Epub 2014 Mar 7. Ann Neurol. 2014. PMID: 24510776 Free PMC article. Clinical Trial.

5

The PRO-ACT database: design, initial analyses, and predictive features.

Atassi N, Berry J, Shui A, Zach N, Sherman A, Sinani E, Walker J, Katsovskiy I, Schoenfeld D, Cudkowicz M, Leitner M. Atassi N, et al. Neurology. 2014 Nov 4;83(19):1719-25. doi: 10.1212/WNL.0000000000000951. Epub 2014 Oct 8. Neurology. 2014. PMID: 25298304 Free PMC article.

6

Relative effects of forced vital capacity and ALSFRS-R on survival in ALS.

Daghlas SA, Govindarajan R; Pooled Resource Open-Access ALS Clinical Trials Consortium. Daghlas SA, et al. Muscle Nerve. 2021 Sep;64(3):346-351. doi: 10.1002/mus.27344. Epub 2021 Jun 10. Muscle Nerve. 2021. PMID: 34076262

7

Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial.

Writing Group; Edaravone (MCI-186) ALS 19 Study Group. Writing Group, et al. Lancet Neurol. 2017 Jul;16(7):505-512. doi: 10.1016/S1474-4422(17)30115-1. Epub 2017 May 15. Lancet Neurol. 2017. PMID: 28522181 Clinical Trial.

8

Model-Based and Model-Free Techniques for Amyotrophic Lateral Sclerosis Diagnostic Prediction and Patient Clustering.

Tang M, Gao C, Goutman SA, Kalinin A, Mukherjee B, Guan Y, Dinov ID. Tang M, et al. Neuroinformatics. 2019 Jul;17(3):407-421. doi: 10.1007/s12021-018-9406-9. Neuroinformatics. 2019. PMID: 30460455 Free PMC article.

9

A retrospective investigation of the relationship between baseline covariates and rate of ALSFRS-R decline in ALS clinical trials.

Daghlas I, Lever TE, Leary E. Daghlas I, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2018 May;19(3-4):206-211. doi: 10.1080/21678421.2017.1418001. Epub 2017 Dec 20. Amyotroph Lateral Scler Frontotemporal Degener. 2018. PMID: 29260911

10

The MITOS system predicts long-term survival in amyotrophic lateral sclerosis.

Tramacere I, Dalla Bella E, Chiò A, Mora G, Filippini G, Lauria G; EPOS Trial Study Group. Tramacere I, et al. J Neurol Neurosurg Psychiatry. 2015 Nov;86(11):1180-5. doi: 10.1136/jnnp-2014-310176. Epub 2015 Apr 17. J Neurol Neurosurg Psychiatry. 2015. PMID: 25886781 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

87 results

Results by year